NCT04698902

Brief Summary

Calcified coronary artery disease is a frequently encountered problem that can lead to poorer outcomes for patients undergoing PCI. Recently, intravascular lithotripsy has become available for the treatment of callcified coronary artery disease. The effect of intravascular lithotripsy on varying calcium patterns has not been adequately explored. This is an investigator initiated, open label, non-blinded, observational study involving a number of centers in Spain examining the effect of intravasuclar lithotripsy in varying calcium patterns. 100 patients wll be enrolled. Optical coherence tomography will be used to assess the effect of intravascular lithotripsy on varying calcium patterns (concentric, eccentric and nodular).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 7, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

January 5, 2021

Last Update Submit

March 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of lesions with Calcium Fractures

    Percentage of lesions showing calcium modification (fractures) after intravascular lithotripsy (IVL) in nodular eccentric and concentric calcium patterns

    At the time of percutaneous coronary intervention

Secondary Outcomes (6)

  • Number of calcium fractures

    At the time of percutaneous coronary intervention

  • Number of quadrants with calcium fractures

    At the time of percutaneous coronary intervention

  • Calcium modification in eccentric versus concentric calcium

    At the time of percutaneous coronary intervention

  • Stent expansion

    At the time of percutaneous coronary intervention

  • Stent symmetry

    At the time of percutaneous coronary intervention

  • +1 more secondary outcomes

Study Arms (3)

Circumferential calcification

Patients with circumferential pattern of coronary artery calcification by OCT (Optical coherence tomography) assessment (arc of calcium \>180 degrees)

Device: Intracoronary lithotripsy

Eccentric calcification

Patients with an eccentric pattern of coronary artery calcification by OCT (Optical coherence tomography) assessment (arc of calcium \<180 degrees)

Device: Intracoronary lithotripsy

Nodular calcification

Patients with calcium nodules identified by OCT (Optical coherence tomography) assessment

Device: Intracoronary lithotripsy

Interventions

Intracoronary lithotripsy involves the use of sonic pressure waves generated from emitters enclosed within a balloon delivery system. The generated sonic waves act to fracture calcium within the coronary artery wall.

Circumferential calcificationEccentric calcificationNodular calcification

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with calcified coronary artery disease planned for percutaneous coronary intervention and stenting with the use of intravascular lithotripsy for calcium modification prior to stenting.

You may qualify if:

  • Patients \>18 years of age
  • Patients with an indication for PCI (ischemic symptoms or evidence of myocardial ischemia (inducible or spontaneous) in the presence of \>50% de novo severely calcified coronary stenosis that requires IVL treatment.

You may not qualify if:

  • Patients unwilling or unable to sign informed consent for the procedure
  • Patients with severe peripheral vascular disease limiting vascular access to the extent that it is unsafe to perform the procedure
  • Patients with severe renal dysfunction (eGFR \<15mls/min and not receiving dialysis)
  • Treatment of vessels \< 2.5mm diameter which are not amenable to IVL treatment or OCT assessment.
  • Treatment of lesions located very distally in the coronary vessel where the OCT catheter may not reach.
  • Inability to cross the lesion with the OCT catheter due to very severe stenosis or severe vessel tortuosity.
  • Ostial left main stem or right coronary artery lesions which may be difficult to visualise by OCT
  • Patients requiring concomitant use of rotational or orbital atherectomy of LASER.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico San Carlos

Madrid, 28040, Spain

Location

MeSH Terms

Conditions

Coronary Artery DiseaseCalcinosis

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

January 5, 2021

First Posted

January 7, 2021

Study Start

November 1, 2020

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

March 6, 2024

Record last verified: 2024-03

Locations